Purpose: The hypothesis addressed by this study is that a glutamine synthetase (GS) deficiency in neoplastic astrocytes is a possible molecular basis associated with seizure generation in glioblastoma multiforme (GBM). Methods: Quantitative Western blot analysis of GS wasperformed in 20 individuals operated for malignant glioma. Results: The levels of GS inpatients with GBM and epilepsy were significantly lower (range 0.04-1.15; mean 0.35 ± 0.36; median 0.25) than in non-epileptic GBM individuals (range 0.78-3.97; mean 1.64 ± 0.99; median 1.25; P = 0.002). No relationship has been found between histological features (i.e. necrosis, gliosis, stroma, inflammatory cells, giant cells, and haemosiderine) and GSM expression or epilepsy. Discussion: Even though the epileptogenesis in glioma is multifactorial, it is conceivable that a down-regulation of GS may have an important pro-epileptogenic role in GBM, through the slowing of glutamate-glutamine cycle. This study suggests that seizures in GBM are coupled with a highly localized enzyme deficiency. The manipulation of GS activity might constitute a novel principle for inhibiting seizures in patients with glioma epilepsy. © Springer Science+Business Media, LLC. 2009.

Epilepsy in glioblastoma multiforme: Correlation with glutamine synthetase levels

Marconi S.;Padovani A.;
2009-01-01

Abstract

Purpose: The hypothesis addressed by this study is that a glutamine synthetase (GS) deficiency in neoplastic astrocytes is a possible molecular basis associated with seizure generation in glioblastoma multiforme (GBM). Methods: Quantitative Western blot analysis of GS wasperformed in 20 individuals operated for malignant glioma. Results: The levels of GS inpatients with GBM and epilepsy were significantly lower (range 0.04-1.15; mean 0.35 ± 0.36; median 0.25) than in non-epileptic GBM individuals (range 0.78-3.97; mean 1.64 ± 0.99; median 1.25; P = 0.002). No relationship has been found between histological features (i.e. necrosis, gliosis, stroma, inflammatory cells, giant cells, and haemosiderine) and GSM expression or epilepsy. Discussion: Even though the epileptogenesis in glioma is multifactorial, it is conceivable that a down-regulation of GS may have an important pro-epileptogenic role in GBM, through the slowing of glutamate-glutamine cycle. This study suggests that seizures in GBM are coupled with a highly localized enzyme deficiency. The manipulation of GS activity might constitute a novel principle for inhibiting seizures in patients with glioma epilepsy. © Springer Science+Business Media, LLC. 2009.
File in questo prodotto:
File Dimensione Formato  
J Neurooncol 2009 Epilepsy.pdf

solo utenti autorizzati

Tipologia: Documento in Post-print
Licenza: Copyright dell'editore
Dimensione 209.29 kB
Formato Adobe PDF
209.29 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/570230
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 51
social impact